ArticleScientific reports2022
Facile synthesis of hierarchically structured MIL-53(Al) with superior properties using an environmentally-friendly ultrasonic method for separating lead ions from aqueous solutions.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Membranes Based on Metal-Organic Framework Nanostructures for Recovering Nickel, Cobalt, and Manganese Ions from Spent Lithium-Ion Batteries.ACS applied nano materials · 2026Article
- MOF MIL-53(Al) catalyzed hydroacylation of azodicarboxylates: sustainable catalyst for heterogeneous acylhydrazide synthesis.RSC advances · 2025Article
- Synthesis and characterization of Al-based metal-organic framework with superior performance for adsorptive desulfurization of model fuel.Scientific reports · 2025Article
- Engineering MIL-53(Al) MOF with Carbon Dots for Synergistic Photocatalysis Applications in Organic Dye Degradation.ACS omega · 2025Article
- Novel Ni/Fe-MIL-53@ZnO nanocomposite for efficient photodegradation of aflatoxins G1 and G2.Scientific reports · 2025Article
- Dispersive micro-solid phase extraction based on two MOFs as highly effective adsorbents for analysis of nilotinib in plasma and wastewater.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2024Article
- Enhanced Cataluminescence Sensor Based on SiOMolecules (Basel, Switzerland) · 2024Article
- Microwave-Responsive Metal-Organic Frameworks (MOFs) for Enhanced In Vitro Controlled Release of Doxorubicin.Nanomaterials (Basel, Switzerland) · 2024Article
- Review
- Selective adsorption of anionic and cationic dyes on mesoporous UiO-66 synthesized using a template-free sonochemistry method: kinetic, isotherm and thermodynamic studies.RSC advances · 2023Article
- Effective removal of Pb(II) ions using piperazine-modified magnetic graphene oxide nanocomposite; optimization by response surface methodology.Scientific reports · 2022Article
- Preparation of Magnetic MIL-68(Ga) Metal-Organic Framework and Heavy Metal Ion Removal Application.Molecules (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study aims at investigating sonochemically synthesized MIL-53(Al) and its applications in adsorption lead ions from aqueous solution. XRD, FESEM, BET, and FTIR analyses were employed to identify and characterize MIL-53(Al). The ultrasonic-assisted synthesis procedure results in reducing the synthesis time to 24 h; however, the conventional synthesis of MIL-53(Al) takes 3 days. Applying ultrasonic waves also leads to increase of the specific surface area up to 50% more than that of synthesized by the conventional method, as well as creating the hierarchical MIL-53(Al) structure which reduces the mass transfer limitation of ions into internal micropores. The optimum conditions for removing lead ions are pH of 6, Pb
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.